Moss Adams Wealth Advisors LLC Sells 1,444 Shares of UnitedHealth Group Incorporated $UNH

Moss Adams Wealth Advisors LLC cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 32.2% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,041 shares of the healthcare conglomerate’s stock after selling 1,444 shares during the period. Moss Adams Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $949,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Bayforest Capital Ltd boosted its stake in UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd boosted its stake in shares of UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after buying an additional 50 shares during the last quarter. IAG Wealth Partners LLC acquired a new position in shares of UnitedHealth Group during the 1st quarter worth about $42,000. O Brien Wealth Partners LLC boosted its stake in shares of UnitedHealth Group by 74.0% during the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock worth $46,000 after buying an additional 37 shares during the last quarter. Finally, Kentucky Trust Co boosted its stake in shares of UnitedHealth Group by 138.5% during the 1st quarter. Kentucky Trust Co now owns 93 shares of the healthcare conglomerate’s stock worth $49,000 after buying an additional 54 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on UNH shares. Robert W. Baird restated an “underperform” rating and set a $198.00 price objective (down from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. UBS Group restated a “buy” rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Oppenheimer cut their target price on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a research note on Wednesday, July 30th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $440.00 target price on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Finally, Wells Fargo & Company cut their target price on shares of UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating for the company in a research note on Monday, August 4th. Sixteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $358.95.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $344.15 on Monday. The firm has a market capitalization of $311.69 billion, a P/E ratio of 14.91, a P/E/G ratio of 2.24 and a beta of 0.44. The company’s 50 day moving average price is $301.20 and its two-hundred day moving average price is $358.73. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.UnitedHealth Group’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter last year, the firm posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s payout ratio is 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.